Patent · US Expired

Treatment of schizophrenia with ampakines and neuroleptics

US6166008A · kind A · utility

14Cited by

0References

26Claims

0Family size

Assignees

Cortex Pharmaceuticals, Inc. · US
The Regents of the University of California · US

Inventors

Steven A. Johnson · Salt Lake City, US
Gary Lynch · Irvine, US
Gary A. Rogers · Basseterre, KN

Key dates

Filing date	Oct 26, 1998
Grant date	Dec 26, 2000
Priority date	—
Expiry date	Oct 26, 2018

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to treatment of schizophrenia and related psychotic disorders, including enhancement of receptor functioning in synapses in brain networks responsible for higher order behaviors. In a particular aspect, the invention relates to methods for the use of AMPA receptor up-modulators in conjunction with antipsychotics for the treatment of schizophrenia. Kits containing the compositions in appropriate form for administration are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.